Skip to main content
PMC home page
Journal of Clinical and Experimental Hepatology logoLink to Journal of Clinical and Experimental Hepatology
. 2011 Aug 26;1(1):17–26. doi: 10.1016/S0973-6883(11)60114-X

Use of Stem Cells for Liver Diseases—Current Scenario

Ashish Kumar *,†,*, Nirupama Trehan Pati **, Shiv Kumar Sarin *,†
PMCID: PMC3940313  PMID: 25755306

Abstract

End-stage liver disease and liver failure are major health problems worldwide leading to high mortality and morbidity and high healthcare costs. Currently, orthotropic liver transplantation is the only effective treatment available to the patients of end-stage liver disease. However, a serious shortage of liver donors, high cost, and risk of organ rejection are the major obstacles to liver transplantation. Because of the ability of stem cells for differentiation into any tissue type, they have huge potential in therapy of various end-stage or degenerative diseases and traumatic injuries. Stem cell therapy has the potential to provide a valuable adjunct and alternative to liver transplantation and has immense potential in the management of end stage liver disease and liver failure. Stem cell therapy can be mediated by either a direct contribution to the functional hepatocyte population with embryonic, induced pluripotent, or adult stem cells or by promotion of endogenous regenerative processes with bone marrow-derived stem cells. Initial translational studies have been encouraging and have suggested improved liver function in advanced chronic liver disease and enhanced liver regeneration after portal vein embolization and partial hepatic resection. Stem cells infusion in cirrhotic patients has improved liver parameters and could form a viable bridge to transplantation. The present review summarizes basic of stem cell biology relevant to clinicians and an update on recent advances on the management of liver diseases using stem cells.

Keywords: Hepatocyte transplantation, liver transplantation, stem cell

Abbreviations: AFP, alpha (α)-fetoprotein; BM, bone marrow; EPCAM, epithelial cell adhesion molecule; ES, embryonic stem; FSCs, fetal stem cells; hAECs, human amniotic epithelial cells; HPC, hepatic progenitor cells; HSC, hematopoietic stem cells; ICAM, intercellular adhesion molecule; iPSCs, induced pluripotent stem cells; MSCs, mesenchymal stem cells; NCAM, neural cell adhesion molecule; UCB, umbilical cord blood

Full Text

The Full Text of this article is available as a PDF (122.4 KB).

References

  • 1.Schuppan D, Afdhal NH. Liver cirrhosis. Lancet. 2008;371:838–851. doi: 10.1016/S0140-6736(08)60383-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Lorenzini S, Gitto S, Grandini E, Andreone P, Bernardi M. Stem cells for end stage liver disease: how far have we got? World J Gastroenterol. 2008;14:4593–4599. doi: 10.3748/wjg.14.4593. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Chen Z, Qi LZ, Zeng R, Li HY, Dai LJ. Stem cells and hepatic cirrhosis. Panminerva Med. 2010;52:149–165. [PubMed] [Google Scholar]
  • 4.Vats A, Bielby RC, Tolley NS, Nerem R, Polak JM. Stem cells. Lancet. 2005;366:592–602. doi: 10.1016/S0140-6736(05)66879-1. [DOI] [PubMed] [Google Scholar]
  • 5.Moore KA, Lemischka IR. Stem cells and their niches. Science. 2006;311:1880–1885. doi: 10.1126/science.1110542. [DOI] [PubMed] [Google Scholar]
  • 6.Weissman IL. Stem cells: units of development, units of regeneration, and units in evolution. Cell. 2000;100:157–168. doi: 10.1016/s0092-8674(00)81692-x. [DOI] [PubMed] [Google Scholar]
  • 7.Lodi D, Iannitti T, Palmieri B. Stem cells in clinical practice: applications and warnings. J Exp Clin Cancer Res. 2011;30:9. doi: 10.1186/1756-9966-30-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Mimeault M, Hauke R, Batra SK. Stem cells: a revolution in therapeutics-recent advances in stem cell biology and their therapeutic applications in regenerative medicine and cancer therapies. Clin Pharmacol Ther. 2007;82:252–264. doi: 10.1038/sj.clpt.6100301. [DOI] [PubMed] [Google Scholar]
  • 9.Pai M, Zacharoulis D, Milicevic MN. Autologous infusion of expanded mobilized adult bone marrow-derived CD34+ cells into patients with alcoholic liver cirrhosis. Am J Gastroenterol. 2008;103:1952–1958. doi: 10.1111/j.1572-0241.2008.01993.x. [DOI] [PubMed] [Google Scholar]
  • 10.Lyra AC, Soares MBP, da Silva LFM. Feasibility and safety of autologous bone marrow mononuclear cell transplantation in patients with advanced chronic liver disease. World J Gastroenterol. 2007;13:1067–1073. doi: 10.3748/wjg.v13.i7.1067. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.am Esch JS, 2nd, Knoefel WT, Klein M. Portal application of autologous CD133+ bone marrow cells to the liver: a novel concept to support hepatic regeneration. Stem Cells. 2005;23:463–470. doi: 10.1634/stemcells.2004-0283. [DOI] [PubMed] [Google Scholar]
  • 12.Bryder D, Rossi DJ, Weissman IL. Hematopoietic stem cells: the paradigmatic tissue-specific stem cell. Am J Pathol. 2006;169:338–346. doi: 10.2353/ajpath.2006.060312. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Körbling M, Katz RL, Khanna A. Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cells. N Engl J Med. 2002;346:738–746. doi: 10.1056/NEJMoa3461002. [DOI] [PubMed] [Google Scholar]
  • 14.Gilchrist ES, Plevris JN. Bone marrow-derived stem cells in liver repair: 10 years down the line. Liver Transpl. 2010;16:118–129. doi: 10.1002/lt.21965. [DOI] [PubMed] [Google Scholar]
  • 15.Yamazaki S, Miki K, Hasegawa K, Sata M, Takayama T, Makuuchi M. Sera from liver failure patients and a demethylating agent stimulate transdifferentiation of murine bone marrow cells into hepatocytes in coculture with nonparenchymal liver cells. J Hepatol. 2003;39:17–23. doi: 10.1016/s0168-8278(03)00150-8. [DOI] [PubMed] [Google Scholar]
  • 16.Sellamuthu S, Manikandan R, Thiagarajan R. In vitro transdifferentiation of human umbilical cord derived hematopoietic stem cells into hepatocyte like cells using combination of growth factors for cell based therapy. Cytotechnology. 2011;63:259–268. doi: 10.1007/s10616-011-9337-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Yannaki E, Anagnostopoulos A, Kapetanos D. Lasting amelioration in the clinical course of decompensated alcoholic cirrhosis with boost infusions of mobilized peripheral blood stem cells. Exp Hematol. 2006;34:1583–1587. doi: 10.1016/j.exphem.2006.06.012. [DOI] [PubMed] [Google Scholar]
  • 18.Terai S, Ishikawa T, Omori K. Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy. Stem Cells. 2006;24:2292–2298. doi: 10.1634/stemcells.2005-0542. [DOI] [PubMed] [Google Scholar]
  • 19.Gordon MY, Levicar N, Pai M. Characterization and clinical application of human CD34+ stem/progenitor cell populations mobilized into the blood by granulocyte colony-stimulating factor. Stem Cells. 2006;24:1822–1830. doi: 10.1634/stemcells.2005-0629. [DOI] [PubMed] [Google Scholar]
  • 20.Mohamadnejad M, Namiri M, Bagheri M. Phase 1 human trial of autologous bone marrow-hematopoietic stem cell transplantation in patients with decompensated cirrhosis. World J Gastroenterol. 2007;13:3359–3363. doi: 10.3748/wjg.v13.i24.3359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Mohamadnejad M, Alimoghaddam K, Mohyeddin-Bonab M. Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis. Arch Iran Med. 2007;10:459–466. [PubMed] [Google Scholar]
  • 22.Fürst G, Schulte am Esch J, Poll LW. Portal vein embolization and autologous CD133+ bone marrow stem cells for liver regeneration: initial experience. Radiology. 2007;243:171–179. doi: 10.1148/radiol.2431060625. [DOI] [PubMed] [Google Scholar]
  • 23.Khan AA, Parveen N, Mahaboob VS. Safety and efficacy of autologous bone marrow stem cell transplantation through hepatic artery for the treatment of chronic liver failure: a preliminary study. Transplant Proc. 2008;40:1140–1144. doi: 10.1016/j.transproceed.2008.03.111. [DOI] [PubMed] [Google Scholar]
  • 24.Kharaziha P, Hellström PM, Noorinayer B. Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I-II clinical trial. Eur J Gastroenterol Hepatol. 2009;21:1199–1205. doi: 10.1097/MEG.0b013e32832a1f6c. [DOI] [PubMed] [Google Scholar]
  • 25.Ismail A, Fouad O, Abdelnasser A, Chowdhury A, Selim A. Stem cell therapy improves the outcome of liver resection in cirrhotics. J Gastrointest Cancer. 2010;41:17–23. doi: 10.1007/s12029-009-9092-9. [DOI] [PubMed] [Google Scholar]
  • 26.Kim JK, Park YN, Kim JS. Autologous bone marrow infusion activates the progenitor cell compartment in patients with advanced liver cirrhosis. Cell Transplant. 2010;19:1237–1246. doi: 10.3727/096368910X506863. [DOI] [PubMed] [Google Scholar]
  • 27.Lyra AC, Soares MBP, da Silva LFM. Infusion of autologous bone marrow mononuclear cells through hepatic artery results in a short-term improvement of liver function in patients with chronic liver disease: a pilot randomized controlled study. Eur J Gastroenterol Hepatol. 2010;22:33–42. doi: 10.1097/MEG.0b013e32832eb69a. [DOI] [PubMed] [Google Scholar]
  • 28.Salama H, Zekri A-R, Zern M, Bahnassy A, Loutfy S. Autologous hematopoietic stem cell transplantation in 48 patients with endstage chronic liver diseases. Cell Transplant. 2010;19:1475–1486. doi: 10.3727/096368910X514314. [DOI] [PubMed] [Google Scholar]
  • 29.Salama H, Zekri A-RN, Bahnassy AA. Autologous CD34+ and CD133+ stem cells transplantation in patients with end stage liver disease. World J Gastroenterol. 2010;16:5297–5305. doi: 10.3748/wjg.v16.i42.5297. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Saito T, Okumoto K, Haga H. Potential therapeutic application of intravenous autologous bone marrow infusion in patients with alcoholic liver cirrhosis. Stem Cells Dev [Internet] 2011 May 11 [cited 2011 May 21] Available from: http://www.ncbi.nlm.nih.gov/pubmed/21417817 [DOI] [PubMed]
  • 31.Nikeghbalian S, Pournasr B, Aghdami N. Autologous transplantation of bone marrow-derived mononuclear and CD133(+) cells in patients with decompensated cirrhosis. Arch Iran Med. 2011;14:12–17. [PubMed] [Google Scholar]
  • 32.Kallis YN, Alison MR, Forbes SJ. Bone marrow stem cells and liver disease. Gut. 2007;56:716–724. doi: 10.1136/gut.2006.098442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Satija NK, Singh VK, Verma YK. Mesenchymal stem cell-based therapy: a new paradigm in regenerative medicine. J Cell Mol Med. 2009;13:4385–4402. doi: 10.1111/j.1582-4934.2009.00857.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Gucciardo L, Lories R, Ochsenbein-Kölble N, Done' E, Zwijsen A, Deprest J. Fetal mesenchymal stem cells: isolation, properties and potential use in perinatology and regenerative medicine. BJOG. 2009;116:166–172. doi: 10.1111/j.1471-0528.2008.02005.x. [DOI] [PubMed] [Google Scholar]
  • 35.Kassem M, Kristiansen M, Abdallah BM. Mesenchymal stem cells: cell biology and potential use in therapy. Basic Clin Pharmacol Toxicol. 2004;95:209–214. doi: 10.1111/j.1742-7843.2004.pto950502.x. [DOI] [PubMed] [Google Scholar]
  • 36.Lange C, Bassler P, Lioznov M-V. Liver-specific gene expression in mesenchymal stem cells is induced by liver cells. World J Gastroenterol. 2005;11:4497–4504. doi: 10.3748/wjg.v11.i29.4497. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Porada CD, Zanjani ED, Almeida-Porad G. Adult mesenchymal stem cells: a pluripotent population with multiple applications. Curr Stem Cell Res Ther. 2006;1:365–369. doi: 10.2174/157488806778226821. [DOI] [PubMed] [Google Scholar]
  • 38.Chamberlain J, Yamagami T, Colletti E. Efficient generation of human hepatocytes by the intrahepatic delivery of clonal human mesenchymal stem cells in fetal sheep. Hepatology. 2007;46:1935–1945. doi: 10.1002/hep.21899. [DOI] [PubMed] [Google Scholar]
  • 39.Lee K-D, Kuo TK-C, Whang-Peng J, Chung Y-F, Lin C-T, Chou S-H. In vitro hepatic differentiation of human mesenchymal stem cells. Hepatology. 2004;40:1275–1284. doi: 10.1002/hep.20469. [DOI] [PubMed] [Google Scholar]
  • 40.Sato Y, Araki H, Kato J. Human mesenchymal stem cells xenografted directly to rat liver are differentiated into human hepatocytes without fusion. Blood. 2005;106:756–763. doi: 10.1182/blood-2005-02-0572. [DOI] [PubMed] [Google Scholar]
  • 41.Schwartz RE, Reyes M, Koodie L. Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells. J Clin Invest. 2002;109:1291–1302. doi: 10.1172/JCI15182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Meirelles L da S, Nardi NB. Methodology, biology and clinical applications of mesenchymal stem cells. Front Biosci. 2009;14:4281–4298. doi: 10.2741/3528. [DOI] [PubMed] [Google Scholar]
  • 43.Christ B, Dollinger MM. The generation of hepatocytes from mesenchymal stem cells and engraftment into the liver. Curr Opin Organ Transplant [Internet] 2010 Dec 9 [cited 2011 May 20] Available from: http://www.ncbi.nlm.nih.gov/pubmed/21150616 [DOI] [PubMed]
  • 44.Jung KH, Uhm Y-K, Lim YJ, Yim S-V. Human umbilical cord blood-derived mesenchymal stem cells improve glucose homeostasis in rats with liver cirrhosis. Int J Oncol. 2011;39:137–143. doi: 10.3892/ijo.2011.1016. [DOI] [PubMed] [Google Scholar]
  • 45.Qiao H, Tong Y, Han H. A novel therapeutic regimen for hepatic fibrosis using the combination of mesenchymal stem cells and baicalin. Pharmazie. 2011;66:37–43. [PubMed] [Google Scholar]
  • 46.Overturf K, al-Dhalimy M, Ou CN, Finegold M, Grompe M. Serial transplantation reveals the stem-cell-like regenerative potential of adult mouse hepatocytes. Am J Pathol. 1997;151:1273–1280. [PMC free article] [PubMed] [Google Scholar]
  • 47.Alison M. Liver stem cells: a two compartment system. Curr Opin Cell Biol. 1998;10:710–715. doi: 10.1016/s0955-0674(98)80111-7. [DOI] [PubMed] [Google Scholar]
  • 48.Farber E. Similarities in the sequence of early histological changes induced in the liver of the rat by ethionine, 2-acetylamino-fluorene, and 3′-methyl-4-dimethylaminoazobenzene. Cancer Res. 1956;16:142–148. [PubMed] [Google Scholar]
  • 49.Kisseleva T, Gigante E, Brenner DA. Recent advances in liver stem cell therapy. Curr Opin Gastroenterol. 2010;26:395–402. doi: 10.1097/MOG.0b013e32833a6bec. [DOI] [PubMed] [Google Scholar]
  • 50.Dabeva MD, Shafritz DA. Activation, proliferation, and differentiation of progenitor cells into hepatocytes in the D-galactosamine model of liver regeneration. Am J Pathol. 1993;143:1606–1620. [PMC free article] [PubMed] [Google Scholar]
  • 51.Theise ND, Saxena R, Portmann BC. The canals of Hering and hepatic stem cells in humans. Hepatology. 1999;30:1425–1433. doi: 10.1002/hep.510300614. [DOI] [PubMed] [Google Scholar]
  • 52.Schmelzer E, Zhang L, Bruce A. Human hepatic stem cells from fetal and postnatal donors. J Exp Med. 2007;204:1973–1987. doi: 10.1084/jem.20061603. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Alison MR, Choong C, Lim S. Application of liver stem cells for cell therapy. Semin Cell Dev Biol. 2007;18:819–826. doi: 10.1016/j.semcdb.2007.09.016. [DOI] [PubMed] [Google Scholar]
  • 54.Giorgetti A, Montserrat N, Rodriguez-Piza I, Azqueta C, Veiga A, Izpisúa Belmonte JC. Generation of induced pluripotent stem cells from human cord blood cells with only two factors: Oct4 and Sox2. Nat Protoc. 2010;5:811–820. doi: 10.1038/nprot.2010.16. [DOI] [PubMed] [Google Scholar]
  • 55.Si-Tayeb K, Noto FK, Sepac A. Generation of human induced pluripotent stem cells by simple transient transfection of plasmid DNA encoding reprogramming factors. BMC Dev Biol. 2010;10:81. doi: 10.1186/1471-213X-10-81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Yamanaka S. A fresh look at iPS cells. Cell. 2009;137:13–17. doi: 10.1016/j.cell.2009.03.034. [DOI] [PubMed] [Google Scholar]
  • 57.Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663–676. doi: 10.1016/j.cell.2006.07.024. [DOI] [PubMed] [Google Scholar]
  • 58.Takahashi K, Tanabe K, Ohnuki M. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131:861–872. doi: 10.1016/j.cell.2007.11.019. [DOI] [PubMed] [Google Scholar]
  • 59.Yu J, Vodyanik MA, Smuga-Otto K. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007;318:1917–1920. doi: 10.1126/science.1151526. [DOI] [PubMed] [Google Scholar]
  • 60.Soto-Gutierrez A, Tafaleng E, Kelly V, Roy-Chowdhury J, Fox IJ. Modeling and therapy of human liver diseases using induced pluripotent stem cells: how far have we come? Hepatology. 2011;53:708–711. doi: 10.1002/hep.24143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Chun YS, Chaudhari P, Jang Y-Y. Applications of patient-specific induced pluripotent stem cells; focused on disease modeling, drug screening and therapeutic potentials for liver disease. Int J Biol Sci. 2010;6:796–805. doi: 10.7150/ijbs.6.796. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Karumbayaram S, Novitch BG, Patterson M. Directed differentiation of human-induced pluripotent stem cells generates active motor neurons. Stem Cells. 2009;27:806–811. doi: 10.1002/stem.31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Si-Tayeb K, Noto FK, Nagaoka M. Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells. Hepatology. 2010;51:297–305. doi: 10.1002/hep.23354. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Zhang D, Jiang W, Liu M. Highly efficient differentiation of human ES cells and iPS cells into mature pancreatic insulin-producing cells. Cell Res. 2009;19:429–438. doi: 10.1038/cr.2009.28. [DOI] [PubMed] [Google Scholar]
  • 65.Zhang J, Wilson GF, Soerens AG. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res. 2009;104:e30–e41. doi: 10.1161/CIRCRESAHA.108.192237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Nishikawa S-ichi, Goldstein RA, Nierras CR. The promise of human induced pluripotent stem cells for research and therapy. Nat Rev Mol Cell Biol. 2008;9:725–729. doi: 10.1038/nrm2466. [DOI] [PubMed] [Google Scholar]
  • 67.Asgari S, Pournasr B, Salekdeh GH, Ghodsizadeh A, Ott M, Baharvand H. Induced pluripotent stem cells: a new era for hepatology. J Hepatol. 2010;53:738–751. doi: 10.1016/j.jhep.2010.05.009. [DOI] [PubMed] [Google Scholar]
  • 68.Yamashita JK. ES and iPS cell research for cardiovascular regeneration. Exp Cell Res. 2010;316:2555–2559. doi: 10.1016/j.yexcr.2010.04.004. [DOI] [PubMed] [Google Scholar]
  • 69.Rashid ST, Corbineau S, Hannan N. Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells. J Clin Invest. 2010;120:3127–3136. doi: 10.1172/JCI43122. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.McDevitt TC, Palecek SP. Innovation in the culture and derivation of pluripotent human stem cells. Curr Opin Biotechnol. 2008;19:527–533. doi: 10.1016/j.copbio.2008.08.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 71.Dalgetty DM, Medine CN, Iredale JP, Hay DC. Progress and future challenges in stem cell-derived liver technologies. Am J Physiol Gastrointest Liver Physiol. 2009;297:G241–G248. doi: 10.1152/ajpgi.00138.2009. [DOI] [PubMed] [Google Scholar]
  • 72.Kasuda S, Tatsumi K, Sakurai Y. Expression of coagulation factors from murine induced pluripotent stem cell-derived liver cells. Blood Coagul Fibrinolysis. 2011;22:271–279. doi: 10.1097/MBC.0b013e328344c63b. [DOI] [PubMed] [Google Scholar]
  • 73.Touboul T, Vallier L, Weber A. Robust differentiation of fetal hepatocytes from human embryonic stem cells and iPS. Med Sci (Paris) 2010;26:1061–1066. doi: 10.1051/medsci/201026121061. [DOI] [PubMed] [Google Scholar]
  • 74.Foster KW, Liu Z, Nail CD. Induction of KLF4 in basal keratinocytes blocks the proliferation-differentiation switch and initiates squamous epithelial dysplasia. Oncogene. 2005;24:1491–1500. doi: 10.1038/sj.onc.1208307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Hochedlinger K, Yamada Y, Beard C, Jaenisch R. Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues. Cell. 2005;121:465–477. doi: 10.1016/j.cell.2005.02.018. [DOI] [PubMed] [Google Scholar]
  • 76.Nair V. Retrovirus-induced oncogenesis and safety of retroviral vectors. Curr Opin Mol Ther. 2008;10:431–438. [PubMed] [Google Scholar]
  • 77.Xu D, Alipio Z, Fink LM. Phenotypic correction of murine hemophilia A using an iPS cell-based therapy. Proc Natl Acad Sci USA. 2009;106:808–813. doi: 10.1073/pnas.0812090106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Song Z, Cai J, Liu Y. Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells. Cell Res. 2009;19:1233–1242. doi: 10.1038/cr.2009.107. [DOI] [PubMed] [Google Scholar]
  • 79.Sullivan GJ, Hay DC, Park I-H. Generation of functional human hepatic endoderm from human induced pluripotent stem cells. Hepatology. 2010;51:329–335. doi: 10.1002/hep.23335. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Funakoshi N, Duret C, Pascussi J-M. Comparison of hepatic-like cell production from human embryonic stem cells and adult liver progenitor cells: CAR transduction activates a battery of detoxification genes. Stem Cell Rev [Internet]. 2011 Jan 6 [cited 2011 May 20] Available from: http://www.ncbi.nlm.nih.gov/pubmed/21210253 [DOI] [PMC free article] [PubMed]
  • 81.Chen X, Zeng F. Directed hepatic differentiation from embryonic stem cells. Protein Cell. 2011;2:180–188. doi: 10.1007/s13238-011-1023-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Agarwal S, Holton KL, Lanza R. Efficient differentiation of functional hepatocytes from human embryonic stem cells. Stem Cells. 2008;26:1117–1127. doi: 10.1634/stemcells.2007-1102. [DOI] [PubMed] [Google Scholar]
  • 83.Yamamoto H, Quinn G, Asari A. Differentiation of embryonic stem cells into hepatocytes: biological functions and therapeutic application. Hepatology. 2003;37:983–993. doi: 10.1053/jhep.2003.50202. [DOI] [PubMed] [Google Scholar]
  • 84.Moriya K, Yoshikawa M, Ouji Y. Embryonic stem cells reduce liver fibrosis in CCl4-treated mice. Int J Exp Pathol. 2008;89:401–409. doi: 10.1111/j.1365-2613.2008.00607.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Heo J, Factor VM, Uren T. Hepatic precursors derived from murine embryonic stem cells contribute to regeneration of injured liver. Hepatology. 2006;44:1478–1486. doi: 10.1002/hep.21441. [DOI] [PubMed] [Google Scholar]
  • 86.Haridass D, Yuan Q, Becker PD. Repopulation efficiencies of adult hepatocytes, fetal liver progenitor cells, and embryonic stem cell-derived hepatic cells in albumin-promoter-enhancer urokinase-type plasminogen activator mice. Am J Pathol. 2009;175:1483–1492. doi: 10.2353/ajpath.2009.090117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Thomson JA, Itskovitz-Eldor J, Shapiro SS. Embryonic stem cell lines derived from human blastocysts. Science. 1998;282:1145–1147. doi: 10.1126/science.282.5391.1145. [DOI] [PubMed] [Google Scholar]
  • 88.Teramoto K, Hara Y, Kumashiro Y. Teratoma formation and hepatocyte differentiation in mouse liver transplanted with mouse embryonic stem cell-derived embryoid bodies. Transplant Proc. 2005;37:285–286. doi: 10.1016/j.transproceed.2004.12.120. [DOI] [PubMed] [Google Scholar]
  • 89.O'Donoghue K, Fisk NM. Fetal stem cells. Best Pract Res Clin Obstet Gynaecol. 2004;18:853–875. doi: 10.1016/j.bpobgyn.2004.06.010. [DOI] [PubMed] [Google Scholar]
  • 90.Ilancheran S, Michalska A, Peh G, Wallace EM, Pera M, Manuelpillai U. Stem cells derived from human fetal membranes display multilineage differentiation potential. Biol Reprod. 2007;77:577–588. doi: 10.1095/biolreprod.106.055244. [DOI] [PubMed] [Google Scholar]
  • 91.Wei X, Wang CY, Liu QP. In vitro hepatic differentiation of mesenchymal stem cells from human fetal bone marrow. J Int Med Res. 2008;36:721–727. doi: 10.1177/147323000803600414. [DOI] [PubMed] [Google Scholar]
  • 92.Riehle KJ, Dan YY, Campbell JS, Fausto N. New concepts in liver regeneration. J Gastroenterol Hepatol. 2011;26(Suppl 1):203–212. doi: 10.1111/j.1440-1746.2010.06539.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 93.Ruhil S, Kumar V, Rathee P. Umbilical cord stem cell: an overview. Curr Pharm Biotechnol. 2009;10:327–334. doi: 10.2174/138920109787847529. [DOI] [PubMed] [Google Scholar]
  • 94.Mihu CM, Mihu D, Costinus Ciuca D, Susman S, Ciortea R. Isolation and characterization of stem cells from the placenta and the umbilical cord. Rom J Morphol Embryol. 2008;49:441–446. [PubMed] [Google Scholar]
  • 95.In't Anker PS, Scherjon SA, Kleijburg-van der Keur C. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells. 2004;22:1338–1345. doi: 10.1634/stemcells.2004-0058. [DOI] [PubMed] [Google Scholar]
  • 96.Crema A, Ledda M, De Carlo F. Cord blood CD133 cells define an OV6-positive population that can be differentiated in vitro into engraftable bipotent hepatic progenitors. Stem Cells Dev [Internet] 2011 Mar 23 [cited 2011 May 20] Available from: http://www.ncbi.nlm.nih.gov/pubmed/21291316 [DOI] [PubMed]

Articles from Journal of Clinical and Experimental Hepatology are provided here courtesy of Elsevier

RESOURCES